vimarsana.com
Home
Live Updates
MorphoSys Enters into Business Combination Agreement to be acquired by Novartis for EUR 2.7 Billion Equity Value : comparemela.com
MorphoSys Enters into Business Combination Agreement to be acquired by Novartis for EUR 2.7 Billion Equity Value
Germany - MorphoSys AG today announced the company entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG based on Novartis' intention to submit a voluntary public...
Related Keywords
Canada ,
United States ,
Massachusetts ,
Germany ,
Boston ,
Planegg ,
Bayern ,
German ,
Thomas Biegi ,
Julia Neugebauer ,
Jean Paul Kress ,
German Federal Financial Supervisory Authority Bafin ,
Company Annual Report On Form ,
Lymphoma Society ,
Drug Administration ,
Constellation Pharmaceuticals Inc ,
Xencor Inc ,
Exchange Commission ,
Incyte Corporation ,
Novartis ,
Nasdaq ,
Business Combination Agreement ,
Purchase Agreement ,
Supervisory Board ,
Paul Kress ,
Chief Executive Officer ,
Certain Cash Value ,
New Opportunities ,
German Securities Acquisition ,
Takeover Act ,
Federal Financial Supervisory Authority ,
Tender Offer Statement ,
Recommendation Statement ,
Antibody Dependent Cell Mediated Cytotoxicity ,
Antibody Dependent Cellular Phagocytosis ,
Takeover Offer ,
Annual Report ,
Takeover Offer Documents ,
News Publishing ,
Markets ,
comparemela.com © 2020. All Rights Reserved.